Mast cell activation syndrome Treatment is directed at preventing mediator release (eg, with cromolyn and / or ketotifen) and blocking mediator effects with some regimen of H1 and H2 blockers to block histamine, aspirin to block prostaglandins and montelukast to block leukotrienes.